Published in Nephron Physiol on January 01, 2004
Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat Clin Pract Nephrol (2007) 1.43
Hypoxia and oxidative stress markers in pediatric patients undergoing hemodialysis: cross section study. BMC Nephrol (2012) 0.82
Circulating beta chemokine and MMP 9 as markers of oxidative injury in extremely low birth weight infants. Pediatr Res (2010) 0.80
Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis. Pediatr Nephrol (2006) 0.80
Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives. Clin Dev Immunol (2012) 0.76
Positive relationship between total antioxidant status and chemokines observed in adults. Oxid Med Cell Longev (2014) 0.75
Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option? Eur J Nucl Med Mol Imaging (2011) 2.08
Tissue factor and thrombomodulin in hemodialysis patients: associations with endothelial injury, liver disease, and erythropoietin therapy. Clin Appl Thromb Hemost (2002) 1.72
Peripheral blood level alterations of MMP-2 and MMP-9 in patients with chronic kidney disease on conservative treatment and on hemodialysis. Clin Biochem (2011) 1.50
Effects of enoxaparin on myeloperoxidase release during hemodialysis. Hemodial Int (2014) 1.44
Endothelial injury markers with high-dose intravenous iron therapy in renal failure. Clin Appl Thromb Hemost (2004) 1.39
Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent. Nucl Med Biol (2009) 1.16
Hepcidin in anemia and inflammation in chronic kidney disease. Kidney Blood Press Res (2007) 1.14
Oxidative stress - a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients. Am J Nephrol (2004) 1.12
Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients. Clin J Am Soc Nephrol (2011) 1.09
Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7). Hypertension (2002) 1.09
Letter on 'sodium-dependent modulation of systemic and urinary renalase expression and activity in the rat remnant kidney'. J Hypertens (2013) 1.07
Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation. Kidney Blood Press Res (2009) 1.04
Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients. Atherosclerosis (2006) 0.98
Renalase, stroke, and hypertension in hemodialyzed patients. Ren Fail (2012) 0.97
Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res (2003) 0.93
The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. Atherosclerosis (2008) 0.93
Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients. Thromb Res (2007) 0.92
Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Am J Hematol (2006) 0.92
Risk factors of nontunneled noncuffed hemodialysis catheter malfunction. A prospective study. Nephron Clin Pract (2004) 0.91
Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients. Med Sci Monit (2006) 0.91
Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients. Clin Transplant (2009) 0.88
Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients--role of oxidative stress. Cytokine (2005) 0.88
Low molecular weight iron dextran increases fibroblast growth factor-23 concentration, together with parathyroid hormone decrease in hemodialyzed patients. Ther Apher Dial (2012) 0.88
Renalase, a novel enzyme involved in blood pressure regulation, is related to kidney function but not to blood pressure in hemodialysis patients. Kidney Blood Press Res (2012) 0.88
Renalase, hypertension, and kidney - the discussion continues. Angiology (2012) 0.87
Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease. Clin Biochem (2006) 0.87
Oxidized LDL to autoantibodies against oxLDL ratio - the new biomarker associated with carotid atherosclerosis and cardiovascular complications in dialyzed patients. Atherosclerosis (2012) 0.86
Repeated cycles of peptide receptor radionuclide therapy (PRRT)--results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET. Radiother Oncol (2011) 0.86
Hyporesponsiveness to erythropoietin therapy in hemodialyzed patients: potential role of prohepcidin, hepcidin, and inflammation. Ren Fail (2009) 0.86
The cardio-renal-anaemia syndrome predicts survival in peritoneally dialyzed patients. Arch Med Sci (2010) 0.86
Markers of endothelial damage in patients on hemodialysis and hemodiafiltration. J Nephrol (2006) 0.86
Renalase in peritoneal dialysis patients is not related to blood pressure, but to dialysis vintage. Perit Dial Int (2012) 0.86
Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy. Kidney Blood Press Res (2009) 0.86
Kidney and liver kynurenine pathway enzymes in chronic renal failure. Adv Exp Med Biol (2003) 0.86
Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab (2004) 0.85
VAP-1, a novel molecule linked to endothelial damage and kidney function in kidney allograft recipients. Kidney Blood Press Res (2012) 0.85
GDF15 is related to anemia and hepcidin in kidney allograft recipients. Nephron Clin Pract (2013) 0.84
Vascular adhesion protein-1 and renalase in regard to diabetes in hemodialysis patients. Arch Med Sci (2012) 0.84
Intravenous and oral sulodexide versus coagulation activation markers in humans. Clin Appl Thromb Hemost (2009) 0.84
Sulodexide for hemodialysis anticoagulation in heparin-induced thrombocytopenia type II. J Nephrol (2007) 0.84
Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients. Thromb Haemost (2009) 0.84
Elevated resistin is related to inflammation and residual renal function in haemodialysed patients. Nephrology (Carlton) (2007) 0.84
Kynurenine, quinolinic acid--the new factors linked to carotid atherosclerosis in patients with end-stage renal disease. Atherosclerosis (2008) 0.84
Circulating levels of renalase, norepinephrine, and dopamine in dialysis patients. Ren Fail (2013) 0.83
Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin. Ren Fail (2009) 0.83
Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Clin Biochem (2005) 0.83
Systemic levels of MMP2/TIMP2 and cardiovascular risk in CAPD patients. Nephron Clin Pract (2010) 0.83
Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs). Eur J Nucl Med Mol Imaging (2011) 0.82
Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis? Transl Res (2012) 0.82
Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients? Life Sci (2013) 0.81
How often do we see incidental 68Ga-DOTATATE thyroid uptake in PET/CT in patients with neuroendocrine tumours? Endokrynol Pol (2015) 0.81
The concentration of kynurenine in rat model of asthma. Folia Histochem Cytobiol (2008) 0.81
Comparison of receptor affinity of natSc-DOTA-TATE versus natGa-DOTA-TATE. Nucl Med Rev Cent East Eur (2011) 0.81
Kynurenine and its metabolites--kynurenic acid and anthranilic acid are associated with soluble endothelial adhesion molecules and oxidative status in patients with chronic kidney disease. Am J Med Sci (2009) 0.81
Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease. Am J Nephrol (2004) 0.81
Hepcidin is linked to anemia and inflammation in peritoneal dialysis patients. Perit Dial Int (2008) 0.81
Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patients. Cytokine (2006) 0.80
Thyroid function, endothelium, and inflammation in hemodialyzed patients: possible relations? J Ren Nutr (2007) 0.80
The effect of endurance training on regional serotonin metabolism in the brain during early stage of detraining period in the female rat. Cell Mol Neurobiol (2006) 0.80
Visfatin and endothelial function in dialyzed patients. Nephrology (Carlton) (2010) 0.80
Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment. Blood Coagul Fibrinolysis (2009) 0.80
Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related? Nephrol Dial Transplant (2005) 0.80
Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients. Cytokine (2004) 0.80
Possible relationship between neutrophil gelatinase-associated lipocalin, hepcidin, and inflammation in haemodialysed patients. Nephron Clin Pract (2010) 0.79
Pleiotropic effects of heparin and heparinoids in peritoneal dialysis. Clin Appl Thromb Hemost (2007) 0.79
Kidney disease is a negative predictor of 30-day survival after acute ischaemic stroke. Nephron Clin Pract (2009) 0.79
Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism. Int Urol Nephrol (2011) 0.79
Extrinsic coagulation pathway activation and metalloproteinase-2/TIMPs system are related to oxidative stress and atherosclerosis in hemodialysis patients. Thromb Haemost (2004) 0.79
[Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure]. Pol Arch Med Wewn (2005) 0.79
Kynurenine metabolism in central nervous system in experimental chronic renal failure. Adv Exp Med Biol (2003) 0.78
Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation. Nucl Med Biol (2009) 0.78
A frequency and semiquantitative analysis of pathological 68Ga DOTATATE PET/CT uptake by primary site-dependent neuroendocrine tumor metastasis. Clin Nucl Med (2014) 0.78
Carotid atherosclerosis is associated with enhanced beta-chemokine levels in patients on continuous ambulatory peritoneal dialysis. Atherosclerosis (2005) 0.78
Long-term erythropoietin therapy decreases CC-chemokine levels and intima-media thickness in hemodialyzed patients. Am J Nephrol (2006) 0.78
Relationship between oxidative stress and extrinsic coagulation pathway in haemodialyzed patients. Thromb Res (2003) 0.78
Sulodexide induces hepatocyte growth factor release in humans. Eur J Pharmacol (2006) 0.77
Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure. Cytokine (2008) 0.77
Value of the real-time myocardial contrast echocardiography for risk stratification and for the detection of significant coronary stenosis in patients with end-stage renal disease. Nephrol Dial Transplant (2006) 0.77
Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity. Thromb Res (2006) 0.77
Oxidative stress effects fibrinolytic system in dialysis uraemic patients. Thromb Res (2005) 0.77